OBJECTIVE:to verify depressive symptoms and adherence to chemotherapy among women with
breast cancer who are served by the Pharmacy of the Chemotherapy Center of a
university hospital.METHOD: cross-sectional study with quantitative approach conducted with 112 women
receiving chemotherapy. Structured interviews guided by a script addressing
socio-demographic, clinical and therapeutic information, the Morisky Test, and the
Beck Depression Inventory were used to collect data. RESULTS: 12.50% and 1.78% of the patients experienced "moderate" and "severe" depression,
respectively, while 10.59% did not use antidepressant medication. A statistically
significant association was found between levels of depression and the use of
antidepressants. Lack of adherence was identified in 46.43% of the participants.
CONCLUSION: these findings show the need to regularly screen for depressive symptoms and for
adherence to chemotherapy treatment among women with breast cancer, in order to
provide early detection and appropriate treatment centered on patients, and to
improve their quality of life.